Vantage Consulting Group Inc Biomarin Pharmaceutical Inc Put Options Transaction History
Vantage Consulting Group Inc
- $9.74 Million
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BMRN
# of Institutions
683Shares Held
189MCall Options Held
1.31MPut Options Held
1.09M-
Black Rock Inc. New York, NY22.7MShares$1.23 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.6MShares$1.01 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA15.2MShares$826 Million0.65% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$796 Million0.46% of portfolio
-
Viking Global Investors LP12.3MShares$666 Million2.14% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $10.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...